Product Description

ERYPEG 30 MCG PFS contains Methoxy Polyethylene Glycol Epoetin Beta 30 mcg, a long acting erythropoiesis stimulating agent that helps stimulate red blood cell production. It is used for the treatment of anemia associated with chronic kidney disease under qualified medical supervision.

🔹 Key Uses

Treatment of anemia associated with chronic kidney disease

Helps increase red blood cell production in patients with reduced erythropoietin levels

Helps improve hemoglobin levels in appropriate patients

May reduce the need for red blood cell transfusions in selected patients

🔹 Composition

Methoxy Polyethylene Glycol Epoetin Beta 30 mcg

🔹 How It Works

Methoxy polyethylene glycol epoetin beta works similarly to natural erythropoietin by stimulating receptors on bone marrow cells. This promotes the production of red blood cells and helps improve hemoglobin levels.

🔹 Key Benefits

Helps stimulate red blood cell production

Helps improve hemoglobin levels

May reduce the need for blood transfusions in selected patients

Provides long acting erythropoietin activity

Supports the management of anemia associated with chronic kidney disease

🔹 Dosage and Administration

The dose and treatment schedule depend on the patients hemoglobin level, kidney function, response to treatment, and other medical factors. ERYPEG 30 MCG PFS is administered by subcutaneous or intravenous injection according to the medical indication and healthcare professionals instructions. Regular monitoring of hemoglobin and blood pressure may be required.

🔹 Possible Side Effects

High blood pressure

Headache

Nausea

Fever

Injection site reactions

Joint or muscle pain

Blood clots

Seizures

🔹 Precautions and Warnings

ERYPEG 30 MCG PFS should be used under qualified medical supervision.

Blood pressure and hemoglobin levels should be monitored regularly during treatment.

Erythropoiesis stimulating agents can increase the risk of serious cardiovascular events and blood clots, particularly when hemoglobin levels become too high.

Inform the doctor about uncontrolled high blood pressure, heart disease, history of blood clots, or seizures before treatment.

Iron levels should be assessed and maintained as adequate iron is important for an effective response to treatment.

Do not change the dose or treatment schedule without medical advice.

Seek immediate medical attention for chest pain, sudden difficulty breathing, severe headache, weakness on one side of the body, or swelling and pain in an arm or leg.